These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 28847036)

  • 1. Functional Imaging and Assessment of Antitumor Activity in Systemic Therapy for Hepatocellular Carcinoma.
    Kambadakone A; Baliyan V; Zhu AX
    Semin Liver Dis; 2017 Aug; 37(3):259-274. PubMed ID: 28847036
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of tumor response to systemic therapy in hepatocellular carcinoma.
    Gafton B; Pârciu S; Murguleţ E; Bălan G
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(4):1005-10. PubMed ID: 23700879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reproducibility of European Association for the Study of the Liver criteria and modified Response Evaluation Criteria in Solid Tumors in patients treated with sorafenib.
    Jeon MY; Lee HW; Kim BK; Park JY; Kim DY; Ahn SH; Han KH; Baek SE; Kim HS; Kim SU; Park MS
    Liver Int; 2018 Sep; 38(9):1655-1663. PubMed ID: 29495116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced imaging techniques in the therapeutic response of transarterial chemoembolization for hepatocellular carcinoma.
    Yang K; Zhang XM; Yang L; Xu H; Peng J
    World J Gastroenterol; 2016 May; 22(20):4835-47. PubMed ID: 27239110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in tumor density in patients with advanced hepatocellular carcinoma treated with sunitinib.
    Faivre S; Zappa M; Vilgrain V; Boucher E; Douillard JY; Lim HY; Kim JS; Im SA; Kang YK; Bouattour M; Dokmak S; Dreyer C; Sablin MP; Serrate C; Cheng AL; Lanzalone S; Lin X; Lechuga MJ; Raymond E
    Clin Cancer Res; 2011 Jul; 17(13):4504-12. PubMed ID: 21531821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of different tumor response criteria in patients with hepatocellular carcinoma after systemic therapy with the multikinase inhibitor sorafenib.
    Spira D; Fenchel M; Lauer UM; Claussen CD; Gregor M; Bitzer M; Horger M
    Acad Radiol; 2011 Jan; 18(1):89-96. PubMed ID: 20926315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dramatic reduction in tumour size in hepatocellular carcinoma patients on thalidomide therapy.
    Demeria D; Birchall I; Bain VG
    Can J Gastroenterol; 2007 Aug; 21(8):517-8. PubMed ID: 17703252
    [No Abstract]   [Full Text] [Related]  

  • 8. Early response to anti-tumoral treatment in hepatocellular carcinoma--can quantitative contrast-enhanced ultrasound predict outcome?
    Knieling F; Waldner MJ; Goertz RS; Zopf S; Wildner D; Neurath MF; Bernatik T; Strobel D
    Ultraschall Med; 2013 Feb; 34(1):38-46. PubMed ID: 23258770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution from WHO to EASL and mRECIST for hepatocellular carcinoma: considerations for tumor response assessment.
    Kim MN; Kim BK; Han KH; Kim SU
    Expert Rev Gastroenterol Hepatol; 2015 Mar; 9(3):335-48. PubMed ID: 25370168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma.
    Lencioni R; Llovet JM
    Semin Liver Dis; 2010 Feb; 30(1):52-60. PubMed ID: 20175033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive factors for intrahepatic recurrence after percutaneous ethanol injection therapy for small hepatocellular carcinoma.
    Koda M; Murawaki Y; Mitsuda A; Ohyama K; Horie Y; Suou T; Kawasaki H; Ikawa S
    Cancer; 2000 Feb; 88(3):529-37. PubMed ID: 10649243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete radiological response after sorafenib treatment for advanced hepato-cellular carcinoma.
    Elleuch N; Ennaifer R; Romdhane H; Cheikh M; Hefaiedh R; Bougassas W; Ben Nejma H; BelHadj N
    Tunis Med; 2015 Jun; 93(6):350-2. PubMed ID: 26644095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular carcinoma treated by sorafenib with complete radiological response according to mRECIST criteria: could we stop the treatment? About four cases.
    Poullenot F; Bioulac-Sage P; Laumonier H; Saric J; Carteret T; Blanc JF
    Acta Oncol; 2014 Mar; 53(3):420-3. PubMed ID: 23713857
    [No Abstract]   [Full Text] [Related]  

  • 14. Imaging diagnosis and staging of hepatocellular carcinoma.
    Lee JM; Trevisani F; Vilgrain V; Wald C
    Liver Transpl; 2011 Oct; 17 Suppl 2():S34-43. PubMed ID: 21739567
    [No Abstract]   [Full Text] [Related]  

  • 15. Noninvasive Imaging for Assessment of the Efficacy of Therapeutic Agents for Hepatocellular Carcinoma.
    Liang Q; Kong L; Zhu X; Du Y; Tian J
    Mol Imaging Biol; 2020 Dec; 22(6):1455-1468. PubMed ID: 31834570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced hepatocellular carcinoma: early evaluation of response to bevacizumab therapy at dynamic contrast-enhanced US with quantification--preliminary results.
    Lassau N; Koscielny S; Chami L; Chebil M; Benatsou B; Roche A; Ducreux M; Malka D; Boige V
    Radiology; 2011 Jan; 258(1):291-300. PubMed ID: 20980447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sorafenib: the gold standard therapy in advanced hepatocellular carcinoma and beyond.
    Gadaleta-Caldarola G; Divella R; Mazzocca A; Infusino S; Ferraro E; Filippelli G; Daniele A; Sabbà C; Abbate I; Brandi M
    Future Oncol; 2015; 11(16):2263-6. PubMed ID: 26260805
    [No Abstract]   [Full Text] [Related]  

  • 18. Systemic treatment in advanced/metastatic hepatocellular carcinoma in the era of targeted therapy.
    Han KH; Park JY
    J Gastroenterol Hepatol; 2010 Jun; 25(6):1023-5. PubMed ID: 20594213
    [No Abstract]   [Full Text] [Related]  

  • 19. Regorafenib: a newly approved drug for advanced hepatocellular carcinoma.
    Kyrochristos ID; Ziogas DE; Roukos DH
    Future Oncol; 2017 Aug; 13(19):1665-1668. PubMed ID: 28613123
    [No Abstract]   [Full Text] [Related]  

  • 20. SM5-1-conjugated PLA nanoparticles loaded with 5-fluorouracil for targeted hepatocellular carcinoma imaging and therapy.
    Ma X; Cheng Z; Jin Y; Liang X; Yang X; Dai Z; Tian J
    Biomaterials; 2014 Mar; 35(9):2878-89. PubMed ID: 24411331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.